J9171 HCPCS code: Injection, docetaxel, 1 mg
J9171 is the HCPCS Level II code for injection, docetaxel, 1 mg. In 2024 Medicare paid an average of $0.68 per service for J9171 across 3,891,468 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 300 per day on DME suppliers. Medicare volume fell 10% from 2022 to 2024 (4,339,241 to 3,891,468 services). In 2024, about 4,483 clinicians billed Medicare for J9171 for 9,100 beneficiaries; Texas, Florida, California accounted for 34% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2010-01-01 |
| Last action effective | 2024-01-01 |
Who bills J9171 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 4,483 |
| Medicare beneficiaries | 9,100 |
| States with claims | 46 |
| Share of services in top 3 states (Texas, Florida, California) | 34% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9171, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 4,339,241 | 9,481 | $0.47 | $0.37 |
| 2023 | 4,340,503 | 9,562 | $0.67 | $0.53 |
| 2024 | 3,891,468 | 9,100 | $0.86 | $0.68 |
States with the most J9171 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Texas | 460,374 | $0.68 |
| Florida | 459,640 | $0.69 |
| California | 392,850 | $0.69 |
| Illinois | 208,306 | $0.67 |
| Virginia | 165,213 | $0.69 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 300 | Prescribing Information |
| outpatient hospital claims | 300 | Prescribing Information |
| practitioner claims | 300 | Prescribing Information |
What changed for J9171
- 2010-01-01: J9171 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9171?
J9171 is the HCPCS Level II code for injection, docetaxel, 1 mg. Short descriptor: "Docetaxel injection".
How much does Medicare pay for J9171?
In 2024, the average Medicare payment was $0.68 per service (average allowed $0.86).
Does Medicare cover J9171?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
How many units of J9171 can be billed per day?
300 on DME suppliers; 300 on outpatient hospital claims; 300 on practitioner claims (NCCI medically unlikely edits).
Related J91 codes
- J9100 — Injection, cytarabine, 100 mg
- J9118 — Injection, calaspargase pegol-mknl, 10 units
- J9119 — Injection, cemiplimab-rwlc, 1 mg
- J9120 — Injection, dactinomycin, 0.5 mg
- J9130 — Dacarbazine, 100 mg
- J9144 — Injection, daratumumab, 10 mg and hyaluronidase-fihj
- J9145 — Injection, daratumumab, 10 mg
- J9150 — Injection, daunorubicin, 10 mg
- J9151 — Injection, daunorubicin citrate, liposomal formulation, 10 mg
- J9153 — Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
- J9155 — Injection, degarelix, 1 mg
- J9160 — Injection, denileukin diftitox, 300 micrograms
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9171
- Watch J9171 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9171
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.